AI Science Tracker

Dayhoff Labs

1 discovery from 2026

Discoveries

Horizyn-1 experimentally identifies enzymes for orphan and nonnatural reactions

Researchers used the reaction–protein dual-encoder model Horizyn-1 to prioritize enzyme candidates, then experimentally validated activity in orphan-reaction deorphaning, enzyme-promiscuity tests and nonnatural transformations. For an uncharacterized Thermus aquaticus protein, LC–MS confirmed dCMP kinase activity; a selected transaminase produced noncanonical amino acids from lysine-derived donors, with isotope tracing supporting predominant alpha-amine transfer.

Technology: Horizyn-1

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Researchers used the reaction–protein dual-encoder model Horizyn-1 to prioritize enzyme candidates, then experimentally validated activity in orphan-reaction deorphaning, enzyme-promiscuity tests and nonnatural transformations.
  • Still unknown: Evidence is from specific in-vitro assays and tested sequences/reactions; model retrieval performance and the tested enzyme activities do not establish broad generalization. The paper reports that the predicted CMP kinase activity for one protein was not confirmed, while dCMP activity was.
  • AI role: A contrastive model jointly embedded reaction fingerprints and ProtT5 protein-sequence representations, ranked candidate enzyme–reaction pairs, and informed experimental selection. The authors assayed predictions with biochemical assays, LC–MS and isotope tracing; some fine-tuning results are predictive-performance findings rather than biological discoveries.

Evidence sources: https://doi.org/10.1073/pnas.2520070123

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.